mannide monooleate: Clinical Trials

3 trials of mannide monooleate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 22Completed 2

Follow mannide monooleate: new trials by email Literature Review of mannide monooleate trials Research Report on mannide monooleate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy Study of Plasmodium Falciparum LSA-3 Malaria Vaccine
arm I: PfLSA-3-rec with aluminium hydroxide as adjuvant, arm 2: PfLSA-3-rec with Montanide Isa 720 as adjuvant - Healthy
Phase 1 / Phase 2CompletedRadboud University Medical Center362007-10-012010-02-23
Safety and Immunogenicity Study of Plasmodium Vivax CS Derived Synthetic Peptides Formulated in Two Adjuvants
Peptides (N,R&C) formulated in Montanide ISA 720, Peptides (N,R&C) formulated in Montanide ISA 51, Placebo - Malaria, Vivax
Phase 1CompletedMalaria Vaccine and Drug Development Center402005-07-012010-03-08
Trial to Assess the Efficacy of Malaria Vaccine PfCS 102
PfCS102, Montanide ISA 720 - Plasmodium Falciparum Malaria
Phase 1 / Phase 2CompletedSwiss Tropical & Public Health Institute162004-03-012009-12-14

Conditions studied

Malaria (1)  ·  Malaria, Falciparum (1)  ·  Malaria, Vivax (1)

Sponsors

Malaria Vaccine and Drug Development Center (1)  ·  Radboud University Medical Center (1)  ·  Swiss Tropical & Public Health Institute (1)

Countries

Colombia (1)  ·  Netherlands (1)  ·  Switzerland (1)

Top investigators

Blaise Genton, MD PhD (1)  ·  Myriam Arevalo-Herrera, PhD (1)  ·  Robert Sauerwein, Prof MD (1)

Results publications

PMID 28081133